Meeting logistics and network coordination for the patient engagement and cancer genome sequencing (PE-CGS) network
Ended Awarded Last action
- Contract number
- 75N91024F00001
- Awardee
-
Strategix Management LLC UEI JP6YLTEYJLT5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $14,881
Award facts
- Opportunity
-
- PECGS202001 Solicitation number
- Contract value 9% obligated
-
- $14,880.70 Current, with exercised options
- $166,653.70 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- Competitive 8(a)
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Washington, DC 20037, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$14,156 | |
| Terminate for Convenience | $0 | |
| Original award | $29,037 |
About this award
The National Cancer Institute awarded a competitive 8(a) set-aside delivery order to Strategix Management LLC valued at $166,653.70 for meeting logistics and network coordination services supporting the Patient Engagement and Cancer Genome Sequencing (PE-CGS) Network. Strategix Management, a Washington, D.C.-based minority-owned small business certified in the SBA's 8(a) Program, will perform work at the agency's location in Washington, D.C., with an ultimate completion date of April 30, 2025. The contract utilizes a cost-plus-fixed-fee pricing structure and was awarded on September 18, 2024.
This delivery order is issued under Strategix Management's existing $15 million single-award Indefinite Delivery Contract with the National Cancer Institute established through July 2027 for scientific and technical services support. The firm has demonstrated substantial experience supporting NCI initiatives, having received prior delivery orders exceeding $8.4 million for scientific writing, technical and logistical support to the Tobacco Control Research Branch and Division of Cancer Control and Population Sciences. The PE-CGS Network represents an initiative focused on patient engagement and cancer genomic research, and the logistics and coordination services under this order will support network meetings and operational activities related to this program.
Quick answers
Who was awarded contract 75N91024F00001?
75N91024F00001 was awarded to Strategix Management LLC by National Cancer Institute (National Institutes of Health) on September 18, 2024.
How much is contract 75N91024F00001 worth?
The government has obligated $14,881 on 75N91024F00001. Its potential value, with all options, is $166,654.
Is contract 75N91024F00001 an order under another contract?
Yes. 75N91024F00001 is a delivery order under 75N91022D00010, an indefinite delivery contract.
Was contract 75N91024F00001 competed?
The extent of competition for 75N91024F00001 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award